These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6134430)

  • 1. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
    Friis T; Christensen TR; Gerlach J
    Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
    [No Abstract]   [Full Text] [Related]  

  • 2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of biperiden hydrochloride (Akineton) and benzhexol (Artane) in the treatment of drug-induced Parkinsonism.
    Magnus RV
    J Int Med Res; 1980; 8(5):343-6. PubMed ID: 7418951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study.
    Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M
    J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
    Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
    Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
    J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
    Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110
    [No Abstract]   [Full Text] [Related]  

  • 11. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
    Wada Y; Koshino Y; Yamaguchi N
    Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
    Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
    Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J
    Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects.
    Baldessarini RJ
    Postgrad Med; 1979 Apr; 65(4):123-8. PubMed ID: 34142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal aspects of neuroleptic-induced movement disorders.
    Wettstein RM
    Leg Med; 1985; ():117-79. PubMed ID: 2872562
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
    Hardie RJ; Lees AJ
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):850-4. PubMed ID: 2900293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate in the treatment of levodopa-induced dyskinesia.
    Price PA; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):702-6. PubMed ID: 355601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.